Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy from a First-in-Human Study of Volrustomig, a Novel PD-1/CTLA-4 Bispecific Antibody.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 18, 2025
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors.
Journal: Journal for immunotherapy of cancer
Published: June 09, 2022
Real-world impact of brain metastases on healthcare utilization and costs in patients with non-small cell lung cancer treated with EGFR-TKIs in the US.
Journal: Journal of medical economics
Published: February 12, 2021
Treatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE-028 trial.
Journal: Cancer
Published: June 16, 2020
Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung.
Journal: Journal for immunotherapy of cancer
Published: June 02, 2020
Identifying Resistance Mechanisms to Osimertinib via Blood Biopsy.
Journal: Clinical lung cancer
Published: July 25, 2019
Implementation of the Smoking Treatment and Recovery (STAR) program: healthy cancer survivorship through integrated tobacco control.
Journal: Journal of cancer survivorship : research and practice
Published: July 16, 2019
A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies.
Journal: Cancer chemotherapy and pharmacology
Published: June 21, 2019
Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update.
Journal: Discovery medicine
Published: May 17, 2019
Last Updated: 09/26/2026